Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. - Wikidata - awgldk - TriplyDB

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

http://www.wikidata.org/entity/Q33262244

about

Loss of Niemann Pick type C proteins 1 and 2 greatly enhances HIV infectivity and is associated with accumulation of HIV Gag and cholesterol in late endosomes/lysosomes Deficiency of niemann-pick type C-1 protein impairs release of human immunodeficiency virus type 1 and results in Gag accumulation in late endosomal/lysosomal compartments Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk?Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus Monocytes as regulators of inflammation and HIV-related comorbidities during cART Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism Lipids and membrane microdomains in HIV-1 replication The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction An anti-inflammatory NOD-like receptor is required for microglia development SPTLC1 binds ABCA1 to negatively regulate trafficking and cholesterol efflux activity of the transporter The HIV matrix protein p17 subverts nuclear receptors expression and induces a STAT1-dependent proinflammatory phenotype in monocytes Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.Risk stratification and prognosis of human immunodeficiency virus-infected patients with known or suspected coronary artery disease referred for stress echocardiography.Alternative paths in HIV-1 targeted human signal transduction pathways High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects: Data from the ICONA Foundation Cohort.The Role of Caveolin 1 in HIV Infection and Pathogenesis.Does HIV cause cardiovascular disease?Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk.HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection.Effect of efavirenz on high-density lipoprotein antioxidant properties in HIV-infected patients.New clues to understanding HIV nonprogressors: low cholesterol blocks HIV trans infection.HIV protein Nef causes dyslipidemia and formation of foam cells in mouse models of atherosclerosis.HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications.The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms.Virus vasculopathy and stroke: an under-recognized cause and treatment target.Low cholesterol? Don't brag yet ... hypocholesterolemia blunts HAART effectiveness: a longitudinal study.Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1 The Role of Lipids in Retrovirus Replication.Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux.The scaffolding protein Dlg1 is a negative regulator of cell-free virus infectivity but not of cell-to-cell HIV-1 transmission in T cells Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation.Atherogenic index of plasma in highly active antiretroviral therapy-naïve patients with human immunodeficiency virus infection in Southeast Nigeria Constitutive gene expression in monocytes from chronic HIV-1 infection overlaps with acute Toll-like receptor induced monocyte activation profiles.HIV-1 protein Nef inhibits activity of ATP-binding cassette transporter A1 by targeting endoplasmic reticulum chaperone calnexin Interaction of pathogens with host cholesterol metabolism Impaired lipoprotein processing in HIV patients on antiretroviral therapy: aberrant high-density lipoprotein lipids, stability, and function.Effects of HIV-1-induced CD1c and CD1d modulation and endogenous lipid presentation on CD1c-restricted T-cell activation.Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.

P2860

Q21245090-3FD76E8F-5450-4458-A176-7950090198C7 Q24644759-E7C02E4B-4295-4EC1-9AF0-E3611FB11965 Q26777866-C35DA39C-94C3-401A-BA89-743FBBA512AC Q26851535-22BF41A3-B225-4C0C-AD87-C3A11084B583 Q27006827-F094EFC2-7F41-44CC-B139-3B4AAFDE316E Q27008328-8CAD8B20-146E-49AC-83F4-835BFACF5289 Q27021950-C34F1BB2-3C27-42EB-9CFF-A502D465B643 Q27489393-20E9EC17-F852-47B0-B075-EFD24B7ECF32 Q28386344-87BE4FE6-257E-4B0B-8CF2-C6CF8D2AA5B1 Q28393591-CAEA3159-F71F-4FD7-BA95-AE99CE1B9060 Q28506217-38369714-F445-4342-AB05-1B2DE4F69154 Q28730200-3B4829E1-CA4E-4A17-9088-207C25032BF9 Q30248286-09B43396-5261-4471-815A-7D58311D2893 Q30457521-CB582DD0-A653-4E71-892A-0B319E262A0A Q30951038-B1B31C35-319B-4D72-8184-A931802D0E6C Q31127155-AEEF8128-8BAF-4C5B-8999-89E183E72A85 Q32183747-28A1E8F3-CE07-4E79-A230-D011BD99A931 Q33264851-61E35FC4-3620-4213-8498-8FECA254460E Q33330313-458435FF-AE34-4F0B-8B78-B8658B4D7C4E Q33361587-A746288D-C085-42B0-AB1B-0192E5D08877 Q33556997-827D98D5-C8E3-48D0-BBCA-D76B44A44523 Q33608017-382EDCE9-B0A7-4F8B-8505-E2550C59D6F7 Q33751856-35AD6684-226C-4358-8646-A1622494EE64 Q33775135-35B0DE4B-EC10-4EC0-A9F0-7F40C846519A Q33805298-E4841F38-E85A-4FE6-BA14-A30199E11B54 Q33889580-FC89C926-8C2E-4B4B-A365-C224111AD2DB Q34015853-D0203377-1DEA-450E-8E77-817908ADE6DB Q34028922-E7E2E03E-381A-40E8-A175-9D83B4632073 Q34051644-0BBF74A8-00B0-443F-ADF0-14DF68050345 Q34080779-F18C45DF-036D-41B9-89AE-8B74C3654C19 Q34101172-AC94871D-88C2-4125-984C-4551C8CFF725 Q34137493-F0C1C6BC-13A5-4E53-87BA-A650EF2A8179 Q34146122-CEC0A56F-0500-4EF4-9DB8-0BE78F36E685 Q34228996-14AE88D9-44EA-4F75-AC8B-3D366FCC4C6F Q34345729-45D9A92A-F7AC-4747-87CA-DF4DAEA476B4 Q34355599-5AF3047C-B756-476F-A299-381DFFB0D6E9 Q34451471-040E01B2-3AF1-4618-85AD-66AC8E826586 Q34512603-9FC0D0DA-994D-42F6-BC23-C6B06A7D557A Q34561360-951E3051-41A2-4B72-B145-70DA1575544A Q34673075-113A398A-2EED-431D-A23E-30F5B4014AFC

P2860

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

http://www.wikidata.org/entity/Q33262244

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

@ast

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

@en

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

@nl

type

label

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

@ast

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

@en

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

@nl

prefLabel

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

@ast

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

@en

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

@nl

P1433

Q33262244-4C2A932D-8408-4FAC-BBB0-0576C3CF0459

P1476

Q33262244-4DF712ED-1ECB-438D-A84C-0FE5C552A76B

P2093

Q33262244-0A8EB382-5DF7-4C4B-B2EC-284F34AC4CAD

Q33262244-105496C9-2E2C-49EF-BE59-6060FD781F6A

Q33262244-21F62946-E149-41B9-94F7-1105F3B8B5AA

Q33262244-2A41A89E-E1D3-4AF4-B32E-DABDE0B3F089

Q33262244-4F8CDCEA-9091-4126-ADA9-40F526E7CB0A

Q33262244-576993D7-0D4B-42EC-8C20-A040892F8792

Q33262244-58DB6C28-7F74-4804-AF44-329091698319

Q33262244-9BC989F7-178F-4ABA-8013-AE0B71AACBAF

Q33262244-B9254230-6972-4057-9C1D-2F083A6D6674

Q33262244-E35107FC-0D5F-4ACD-A1FD-1699253830B1

P2860

Q33262244-01137017-27C0-4ABD-8D91-1D867C3EBFAE

Q33262244-0A6504A0-16DE-4AC8-BD8E-22F79D539310

Q33262244-0B2D4703-BBFB-4AE1-B1B2-9CAADB2D9E24

Q33262244-0D0CA73B-38A1-4BC4-B8DE-279D3891DA2C

Q33262244-0D95DF76-2F5E-47CC-AB8B-36B02CF36C29

Q33262244-0E441C86-7D8E-418B-BDFD-602DE2DF3FEE

Q33262244-1514EACC-32A2-4917-A534-D7FE3D382A28

Q33262244-1CC5C0FB-ADC5-4E9F-9D34-BD30E86DF4C4

Q33262244-24C950A1-E646-448F-82BD-A96B8E5BD696

Q33262244-28D81B6D-EF4C-4C32-90CD-D64E9E0B1D81

P304

Q33262244-4CAAE030-D508-43BB-9007-346B4E33C03D

P31

Q33262244-2566E543-08AC-4413-A6D0-A475485A4573

P356

Q33262244-E28392A5-81CF-4337-A5E1-AF5649834781

P407

Q33262244-766F29D0-404E-4DD1-989D-200E8C9CDC8C

P433

Q33262244-2E652550-1918-4470-A033-B66B7AE84E78

P478

Q33262244-D5204070-A848-473F-8872-944CE243ACEF

P50

Q33262244-7988566E-FA02-4260-82C5-C84129C69362

P577

Q33262244-52B4ADB8-CFFB-4BE4-9C64-9A6AAC793DED

P5875

Q33262244-B66BA1B5-3CEC-4253-A8FD-FE25ECE4DE33

P698

Q33262244-382AECED-4109-4458-9EFE-4EE42A40977C

P921

Q33262244-CFDB94D8-EEED-4BCE-80B3-E1EEBAD59D9F

P932

Q33262244-D616833B-8FEE-49AD-B20C-7538E69ABAC8

P356

JOURNAL.PBIO.0040365

P1433

P1476

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

@en

P2093

Dmitri Sviridov

http://www.w3.org/2001/XMLSchema#string

Honor Rose

http://www.w3.org/2001/XMLSchema#string

Jan M Orenstein

http://www.w3.org/2001/XMLSchema#string

Larisa Dubrovsky

http://www.w3.org/2001/XMLSchema#string

Matthew P Morrow

http://www.w3.org/2001/XMLSchema#string

Michael Bukrinsky

http://www.w3.org/2001/XMLSchema#string

Nigora Mukhamedova

http://www.w3.org/2001/XMLSchema#string

Tatiana Pushkarsky

http://www.w3.org/2001/XMLSchema#string

Ying Fu

http://www.w3.org/2001/XMLSchema#string

Yuri V Bobryshev

http://www.w3.org/2001/XMLSchema#string

P2860

Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein

Serine phosphorylation-independent downregulation of cell-surface CD4 by nef

Apolipoprotein specificity for lipid efflux by the human ABCAI transporter

Mechanism for down-regulation of CD28 by Nef.

The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease

Atherosclerosis

Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes

Ritonavir increases the level of active ADD-1/SREBP-1 protein during adipogenesis.

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

Abnormal lipids and the acquired immunodeficiency syndrome: is there a problem and what should we do about it?

P304

e365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PBIO.0040365

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6719136

http://www.w3.org/2001/XMLSchema#string

P698

17076584

http://www.w3.org/2001/XMLSchema#string

P921

P932

1629034

http://www.w3.org/2001/XMLSchema#string